Showing results (261-270 of 764) with videos related to

Sort By:
Pageof 77
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Urology|May 11, 2005
Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literatureAffonso H L A Camargo, Matthew R Cooperberg, Brent D Ershoff, et al.
BJU International|January 3, 2013
Primary treatments for clinically localised prostate cancer: a comprehensive lifetime cost-utility analysisMatthew R Cooperberg, Naren R Ramakrishna, Steven B Duff, et al.
European Urology|February 5, 2014
Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic reviewRoderick C N van den Bergh, Hashim U Ahmed, Chris H Bangma, et al.
Urologic Oncology|January 28, 2009
Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancerBenjamin N Breyer, Jared M Whitson, Peter R Carroll, et al.
The Journal of Urology|November 17, 2009
Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohortMarc C Smaldone, Janet E Cowan, Peter R Carroll, et al.
Urology Practice|March 26, 2019
Variation and Predictors of Surgical Case Costs among UrologistsLindsay A Hampson, Anobel Y Odisho, Maxwell V Meng, et al.
Pageof 77